Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2024 - Mental Daily. All Rights Reserved.
Clinical

BioNTech-Pfizer COVID-19 vaccine labeled as safe for wide-scale distribution by the EU

Staff Writer
Staff Writer 5 years ago
Updated 2021/05/12 at 6:34 PM
Share
SHARE

The exceedingly effective BioNTech-Pfizer vaccine developed for the novel coronavirus has been approved for use by the European Union, providing a first glimpse at hope for its populations.

According to reports, the European Medicines Agency greenlighted its approval by reassuring the vaccine meets the criteria for safeness and quality standards.

The move to begin wide-scale distributions of the new vaccine came at a time when confirmed cases of the recent coronavirus strain had begun to surge in numerous European nations.

But by the end of December, the European Union is expected to receive its deliveries of vaccines from BioNTech-Pfizer, potentially bringing the pandemic to a halt, or at best, minimizing its catastrophe.

BioNTech-Pfizer’s creation is just one of a few vaccines approved for immediate widespread use due to its high-efficiency rates; the other vaccines include Russia’s Sputnik V and another creation by biotechnology giant Moderna.

As of the final days of Q4 2020, the COVID-19 pandemic yielded close to 100 million confirmed cases worldwide and a rising death toll in the millions.

Photo: Yves Herman

You Might Also Like

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

Dementia risk factors differ by ethnicity, according to new research

Researchers investigate how endocannabinoids regulate the brain’s stress response

Study shows the risk of eating disorders may be lower among vegans

TAGGED: COVID-19, epidemiology, European Union
Staff Writer December 21, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New discovery of molecular pathways could explain why some multiple sclerosis patients exhibit seizures
Next Article Most Americans say they changed their holiday plans due to COVID-19 pandemic

Recommended

Clinical

Study explores victim-blaming, manipulation, and denial as tactics used by terrorists

1 Min Read
Clinical

Study finds majority of prisoners receive no visitors, possibly affecting recidivism

2 Min Read
Clinical

Dementia risk factors differ by ethnicity, according to new research

2 Min Read
Clinical

Researchers investigate how endocannabinoids regulate the brain’s stress response

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
  • Mental Health
Follow US

© 2024 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?